MARSHALL MONTEAGLE PLC - Annual Financial Statements for the Year Ended 31 March 2026, Dividend Declaration, Notice of Annual General Meeting
What this filing means
A genuine earnings recovery on a company that needed one. Profit before tax surged to $10.9M from $373K and headline EPS to 25.6 US cents from 2.2c — the operating turn is real and audited. The offset is that the prior year was severely depressed (making the percentage swing mechanically large), the share had risen 6.4% into the print reducing surprise, and an open warrant exercise window plus recent share issuance add meaningful dilution the short-form disclosure does not quantify. Clean audit opinion supports the numbers, but no cash flow, balance sheet or NAV detail is disclosed.
Marshall Monteagle earned a lot more money this year than last, going from almost nothing in profit to over $10 million. That is genuinely good news and the auditors have signed it off. The catch is that last year's profit was abnormally low, so the percentage jump looks bigger than it might feel in a normal year, and the share had already started rising before today. There is also a question mark over how much new share issuance and warrant exercises might dilute what each existing shareholder owns — that detail is not in this short announcement, which only summarises the audited results rather than showing the full accounts.
Bull case
- Profit before tax jumped to $10,871,000 from $373,000, pointing to a substantial operational recovery on continuing operations.
- Total revenue on continuing operations grew to $96,056,000 from $80,997,000, broadening the top line alongside the profit rebound.
- Basic EPS rose to 26.2 US cents from 1.0c, a sharp year-on-year uplift in per-share earnings.
- Headline EPS climbed to 25.6 US cents from 2.2c, indicating the earnings rebound is not driven by one-off items.
- A second interim gross dividend of US 2.10000 cents (ZAR 34.89885 cps) was declared, signalling board confidence in distributable income.
Bear case
- Short-form announcement explicitly states it 'does not contain full or complete details' and 'is itself not audited' — no cash flow statement, balance sheet detail or NAV is disclosed, a critical gap for an investment company.
- Profit surge from $373K to $10.9M reflects recovery off a depressed prior-year base rather than normalised run-rate earnings, while revenue grew a more modest $81.0M to $96.1M [A1,A6].
- Share count expansion is material: weighted average rose to 40.1M (restated) from 36.8M and issued shares at declaration reach 46.1M, indicating recent issuance is diluting per-share metrics [A7,A12].
- An open warrant exercise window (26 Jun–23 Jul 2026) at 19.9422 ZAR per warrant creates an imminent dilution overhang not yet quantified in the announcement [A13,A14].
- Headline EPS of ZAR 4.3831 trails Basic EPS of ZAR 4.4858 and US-cent basic grew 26x while headline grew only ~12x, hinting that non-headline items flattered reported earnings [A2,A3,A4,A5].
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
A real earnings recovery, not spin: PBT at $10.9M vs $373K and headline EPS at 25.6c vs 2.2c represents a genuine operational turnaround confirmed by an unmodified audit. The positive CAR-20 (+6.4%) means the market had begun pricing the improvement before today, so the surprise is real but partially captured — more confirmation than a fresh re-rating event. The short-form disclosure format is the material constraint: no cash flow, balance sheet or NAV is shown, and the dilution from recent issuance and an open warrant window is not quantified. These gaps are bear points that keep conviction mid-range rather than high. So what: the direction is positive, but the market still needs the full annual report to confirm operating cash backs the earnings and to quantify the dilution risk from warrants and share issuance. Missing evidence: No cash flow statement or balance sheet data in short-form announcement; No segmental revenue or profit breakdown for three investment categories; No FY2025 dividend disclosed for year-on-year comparison; No forward guidance or outlook statement provided; No explanation for drivers of profit surge vs prior year; No disclosure of NAV or portfolio valuation movements
The full annual report is where the market will test whether operating cash flow backs the $10.9M profit and whether the dilution from the 46.1M issued share count is fully quantified.
Evidence from the filing
Profit before tax jumped to $10,871,000 from $373,000, pointing to a substantial operational recovery on continuing operations.
“Profit before tax on continuing operations $10,871,000 $373,000”
Total revenue on continuing operations grew to $96,056,000 from $80,997,000, broadening the top line alongside the profit rebound.
“Total revenue on continuing operations $96,056,000 $80,997,000”
Basic EPS rose to 26.2 US cents from 1.0c, a sharp year-on-year uplift in per-share earnings.
“Basic earnings (US$ cents per share) 26.2c 1.0c”
Headline EPS climbed to 25.6 US cents from 2.2c, indicating the earnings rebound is not driven by one-off items.
“Headline earnings (US$ cents per share) 25.6c 2.2c”
A second interim gross dividend of US 2.10000 cents (ZAR 34.89885 cps) was declared, signalling board confidence in distributable income.
“second interim gross dividend for the year ended 31 March 2026 of US$2.10000 cents per share (34.89885 ZAR cents per share)”
Short-form announcement explicitly states it 'does not contain full or complete details' and 'is itself not audited' — no cash flow statement, balance sheet detail or NAV is disclosed, a critical gap for an investment company.
“The 2026 Consolidated Financial Statements were audited by Grant Thornton Limited who issued an unmodified audit opinion thereon”
Profit surge from $373K to $10.9M reflects recovery off a depressed prior-year base rather than normalised run-rate earnings, while revenue grew a more modest $81.0M to $96.1M [A1,A6].
“Profit before tax on continuing operations $10,871,000 $373,000”
Share count expansion is material: weighted average rose to 40.1M (restated) from 36.8M and issued shares at declaration reach 46.1M, indicating recent issuance is diluting per-share metrics [A7,A12].
“The issued number of shares as at declaration date is 46,121,889”
An open warrant exercise window (26 Jun–23 Jul 2026) at 19.9422 ZAR per warrant creates an imminent dilution overhang not yet quantified in the announcement [A13,A14].
“Warrantholders on the South African register should pay 19.9422 ZAR per warrant exercised, being 1.20 US Dollars”
Headline EPS of ZAR 4.3831 trails Basic EPS of ZAR 4.4858 and US-cent basic grew 26x while headline grew only ~12x, hinting that non-headline items flattered reported earnings [A2,A3,A4,A5].
“Headline earnings (rands per share) ZAR 4.3831 ZAR 0.4015”
More on Marshall Monteagle PLC
Related filings
More from MMP
- MARSHALL MONTEAGLE PLC - Dealings in securities by the Chief Executive Officer
- MARSHALL MONTEAGLE PLC - Dealings in securities by the Chief Executive Officer
- MARSHALL MONTEAGLE PLC - Dealings in securities by the Chief Executive Officer
- MARSHALL MONTEAGLE PLC - Dealings in securities by the Chief Executive Officer
- MARSHALL MONTEAGLE PLC - Dealings in securities by the chief executive officer
Other Results
- PHPPRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
- PHPPRIMARY HEALTH PROPERTIES PLC - CANCELLATION OF S524806 Unaudited interim results for the six months ended 30 June 2026
- PHPPRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
- AGLANGLO AMERICAN PLC - Anglo American Interim Results for the Six Months ended 30 June 2026 and Notice of Dividend
- HMNHAMMERSON PLC - Hammerson Half Year Results for the six months ended 30 June 2026